Figure 2
From: APOA1 mRNA and protein in kidney renal clear cell carcinoma correlate with the disease outcome
Survival analyses comparing low and high APOA1 mRNA/methylation in KIRC patients by Grahpad Prism version 9.0 (https://www.graphpad.com/scientific-software/prism/). KIRC patients with low levels of APOA1 mRNA (N = 269) exhibited longer overall survival (A) and disease-free survival (B) time than those with high levels of APOA1 mRNA (N = 268). KIRC patients with APOA1 hypomethylation (N = 159) exhibited longer overall survival (C) and disease-free survival (D) time than those with APOA1 hypermethylation (N = 160).
